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Abstract Chloroplast transformation has many
potential advantages for the production of recombi-
nant proteins in plants. However, it has been reported
that chloroplast expression of many proteins, such as
human epidermal growth factor (hEGF), results hin-
dered by post-transcriptional mechanisms. hEGF
degradation has been related to the redox potential
of the stroma and protein misfolding. To solve this
problem, we proposed the redirection of hEGF into the
thylakoid lumen where the environment could
improve disulfide bonds formation stabilizing the
functional conformation of the protein. We generated
transplastomic tobacco plants targeting hEGF protein
to the thylakoid lumen by adding a transit peptide
(Str). Following this approach, we could detect
thylakoid lumen-targeted hEGF by western blotting
while stromal accumulation of hEGF remained
undetectable. Southern blot analysis confirmed the
integration of the transgene through homologous
recombination into the plastome. Northern blot anal-
ysis showed similar levels of egf transcripts in the EGF
and StrEGF lines. These results suggest that higher
stability of the hEGF peptide in the thylakoid lumen is
the primary cause of the increased accumulation of the
recombinant protein observed in StrEGF lines. They
also highlight the necessity of exploring different sub-
organellar destinations to improve the accumulation
levels of a specific recombinant protein in plastids.
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Introduction
Plants as bioreactors display a huge potential to
produce biopharmaceuticals (Giddings et al. 2000;
Habibi et al. 2019; van Eerde et al. 2019). Compared to
traditional cells bioreactors, molecular pharming
offers lower costs, simple scaling up and improved
biosafety because of the absence of human or animal
pathogens (Obembe et al. 2011; Sparrow and Twyman
2009). However, the accumulation level of recombi-
nant proteins cannot be predicted beforehand and each
case represents a unique challenge (De Marchis et al.
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2012; Giorgi et al. 2010). This is especially relevant
for transplastomic plants. Chloroplast transformation
has many additional advantages to produce therapeu-
tic proteins when compared to other plant-based
expression systems (Bock 2014; Maliga and Bock
2011; Scotti et al. 2012).
Integration into a specific site of the plastid genome
by homologous recombination avoids positional
effects and together with the high ploidy level of the
plastid genome and the absence of gene silencing
reults in high expression levels of recombinant
proteins (De Cosa et al. 2001; Lentz et al. 2010; Oey
et al. 2009).
There are several examples of recombinant proteins
for therapeutic use that have been produced in
transplastomic plants (Burnett and Burnett 2020),
including human growth hormone (hGH) (Staub et al.
2000), serum albumin (Fernandez-San Millan et al.
2003), proinsulin (Ruhlman et al. 2007), interferon-
a2b (Arlen et al. 2007), exendin-4 (Kwon et al. 2013)
and human glutamic acid decarboxylase (Wang et al.
2008).
However, sometimes instability or posttranscrip-
tional mechanisms can prevent the accumulation of
heterologous proteins. A clear example of this limi-
tation has been described in our first attempt to
accumulate in the plastid stroma the mature form of
human epidermal growth factor (hEGF) (Wirth et al.
2006), a 6.2 kDa non-glycosylated polypeptide that
has therapeutic value for the treatment of tissue lesions
such as epidermis wounds (Brown et al. 1989). We
previously showed that, in spite of the presence of the
specific mRNAs in all the transplastomic plants
analyzed, recombinant hEGF was only detected when
stabilized as a fusion to an N-terminal fragment of
Escherichia coli b-glucuronidase (GUS). Moreover,
the accumulation of hEGF in the chloroplasts was
higher in the dark than in the light. These results
suggested that hEGF accumulation is dependent on
correct folding in an environment with proper redox
potential (Wirth et al. 2006).
To achieve high levels of expression, it is necessary
to explore different compartments. In the case of
expression in plastids, proteins have been expressed in
the stroma and in the lumen of thylakoids. These
compartments have their own repertoire of proteases
and chaperones and differences in redox potential that
are known to affect the stability and accumulation of
the recombinant proteins (De Marchis et al. 2012). In
the present work, we explored the redirection of
recombinant hEGF into the thylakoid lumen to
enhance protein accumulation.
This strategy has been successfully exploited to
produce unstable proteins such as phaseolin from bean
(De Marchis et al. 2016) or E7 from human papillo-
mavirus (Morgenfeld et al. 2014) and to improve the
expression of alkaline phosphatase (Bally et al. 2009).
We decided to evaluate the feasibility of accumulating
hEGF in the lumen of the thylakoids. To do this, the
hEGF protein was targeted to this compartment by the
addition of the transit peptide sequence from the
23 kDa protein of the photosystem II oxygen-evolving
system (Str), which was previously used to translocate
recombinant proteins into the thylakoid lumen (Mor-
genfeld et al. 2014). Proteins containing the Str transit
peptide are translocated in a folded conformation
across the thylakoidal membrane by the DpH/TAT
pathway (Albiniak et al. 2012).
In the present study, we expressed the chimera
StrEGF consisting of hEGF fused on its N-terminal
region to the Str transit peptide. StrEGF plants resulted
in higher accumulation levels of hEGF compared to
sromal localization. Unfortuately, the recombinant
protein remained in the insoluble fraction hindering
further progress.
Our work contributes to optimizing hEGF expres-
sion in transplastomic plants by accumulating this
recombinant protein in the thylakoid lumen. This
strategy will require further optimization before this
recombinant protein can be considered for therapeutic
treatment. Overall, the results presented in this work
reinforce the potential of the plastid system within the
field of molecular farming.
Materials and methods
Chloroplast transformation vector construction
Transformation vector pBSW-utr StrEGF was
designed from pBSW-utr StrE7 plasmid (Morgenfeld
et al. 2014) which was previously digested with NdeI
and XbaI restriction enzymes to remove the E7
sequence leaving the vector with the Str signal. The
hEGF sequence was cut from pBSW-utr EGF (Wirth
et al. 2006) with the same restriction enzymes and
subcloned into the aforementioned digested plasmid to
obtain the final transformation vector pBSW-utr
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Fig. 1 Chloroplast transformation vector and analysis of
transgene integration. a Vector pBSW-utr StrEGF contains the
Str bipartite signal from oec23 sequence fused to hEGF
(StrEGF) under the 50 untranslated sequence and the promoter
of the psbA gene (50psbA). The aadA sequence is under the
control of the rrn promoter (Prrn). The left flanking region
(LFR) contain the 30 region of rrn16, and the right flanking
region (RFR) the full trnI and the 50 region of trnA. Vertical
arrows indicate NdeI and XbaI sites utilized for cloning.
b Chloroplast genome physical maps at the insertion site (IS)
of wild type plants (Wt cpDNA) and predicted structure of the
transplastomic genome plant (Tp cpDNA). NcoI restriction sites
and the trnI/A probe used in the Southern blot are indicated.
Horizontal arrows indicate positions of primers utilized for
PCR. Thick lines indicate both regions where recombination is
targeted at rrn16 and TrnIA sequences. c Southern blot using
trnI/A probe 32P-labeled to confirm integration and homo-
plasmy. DNA was digested with NcoI. Position of 1 kb dna
Ladder plus (Invitrogen) is indicated at the left. E, transplas-
tomic line transformed with unfused Hegf; Wt, wild-type; sE1-
3, transplastomic lines transformed with pBSW-utr StrEGF
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StrEGF (Fig. 1). This vector carries the StrhEGF
sequence under the control of the promoter and 50-
untranslated region of the tobacco psbA gene (50psbA)
and downstream the aadA sequence that confers
spectinomycin resistance, under the transcriptional
control of the rrn promoter (Prrn). Flanking regions
were included to allow homologous recombination
with N. tabacum plastome. The left flanking region
(LFR) included the 30 region of rrn16 and the right
flanking region (RFR) contained the full trnI and the 50
region of trnA from N. tabacum.
Chloroplast transformation and molecular
characterization of transgenics plants
Chloroplast transformation was carried out as previ-
ously described (Svab et al. 1990), using a PDS
1000/He biolistic device (Bio-Rad, USA). Briefly,
leaves of in vitro cultured N. tabacum cv. Petit Havana
plants were bombarded with 50 mg of 0.6 lm gold
particles (Bio-Rad) coated with 2 lg of plasmid DNA,
using 1,100 psi rupture disks (Bio-Rad). Transformed
shoots were regenerated in selective RMOP regener-
ation medium containing 500 mg/l spectinomycin
dihydrochloride. To obtain homoplastic plants, leaves
from PCR-positive shoots were taken through two
additional regeneration rounds in selective medium.
Then, plants were transferred to soil and grown in a
greenhouse.
For PCR analysis, DNA obtained from leaf material
was used as template for amplification with primers Cl
Fw (50-GTATCTGGGGAATAAGCATCGG-30) and
Cl Rev (50-CGATGACGCCAACTACCTCTG-30). Cl
Fw hybridizes upstream of the LFR to 16Swt gene and
Cl Rev hybridizes to the aadA sequence. Therefore, a
1450 bp fragment was only amplified from transplas-
tomic plants.
All samples for molecular characterization were
extracted from the third fully expanded leaves starting
from the top of the plant, 5 h after the lighting cycle
begun. The age of the plants sampled was 60–90 days
post-germination.
Southern blot (Dellaporta et al. 1984)
Total DNA was extracted from leaves as described by
Dellaporta et al. (1984). The DNA (2 lg) was digested
overnight with NcoI enzyme (New England Biolabs,
USA), electrophoresed and blotted onto a Hybond
Nylon membrane (Amersham Biosciences, USA).
Specific sequences were detected by hybridization
with a-32P-labeled trnI/A DNA probe. The probe was
generated by random priming with a Prime-a-Gene kit
(Promega, USA). The blot was pre-hybridized,
hybridized, and washed as previously described
(Morgenfeld et al. 2014). The blot was exposed to a
storage phosphor screen, which was analyzed in a
Storm 840 PhosphorImager system (Amersham).
Northern blot
TRiZOL Reagent (Invitrogen Corp., Carlsbad, USA)
was used to extract total RNA from leaves. 4 lg of
denatured RNA was electrophoresed in a 1.5%
agarose/formaldehyde gel and subsequently blotted
onto Hybond N-Nylon membranes (Amersham
Biosciences).
Specific mRNA sequences were detected by
hybridization with a-32P-labeled DNA probe gener-
ated by random priming with a Prime-a-Gene kit
(Promega). The blot was pre- hybridized, hybridized
and washed as described for Southern blot.
Protein extraction and analysis
Total protein extracts were obtained from fully
expanded leaves by processing 25 mg of leaf tissue
in 125 ll of Laemmli sample buffer. For SDS-PAGE,
20 ll of each extract was electrophoresed in 15% gels
and transferred onto nitrocellulose membrane for later
antibody detection.
The blot was probed with a mouse monoclonal
antibody raised against mature EGF of human origin
(Santa Cruz Biotechnology, Inc.). As a secondary
antibody, we use goat IgG anti-mouse IgG linked to
alkaline phosphatase (Cell Signalling Tec.) and
diluted to 1:3000. Phosphatase activity was detected
using 5-bromo-4-chloro-3-indolyl phosphate/nitro
blue tetrazolium (Sigma Chemical Co., USA) as
substrates. For the solubility analysis, 0.2 g of leaf
tissue were ground in liquid nitrogen, mixed with
1 mL of 50 mM Tris–HCl pH 8, 30 mM NaCl,
centrifuged for 15 min at 10,0009g, 4 C, to obtain
an insoluble fraction (I) and a soluble one (S).
For E coli total protein extracts 1 ml culture was
pelleted into microcentrifuge tubes and the super-
natant was discarded. The pellet was resuspended in




Generation of transplastomic N. tabacum plants
expressing StrEGF
The chloroplast transformation vector pBSW-utr-
StrEGF (Fig. 1a) was delivered by particle bombard-
ment to Nicotiana tabacum foliar explants. The vector
includes homology arms that allowed the insertion by
recombination of StrEGF to the intergenic space
between rrn16S and trnI loci (Fig. 1b). From 10
bombardments, we recovered 12 Independent specti-
nomycin-resistant shoots. 9 of them were analyzed by
western blot and hEGF expression was confirmed in
only 6 lines. Three out of these were further charac-
terized by PCR using primers that anneal to the 16S
plastidic gene and to the aadA gene. Therefore, a
1450 bp fragment was amplified only in transplas-
tomic plants (data not shown). These plants were
subjected to two additional regeneration rounds on
selective media. Finally, they were transferred to soil
and grown under greenhouse conditions. These plants
were employed for subsequent analysis.
Analysis of transgene integration in transformed
plants
Transgene integration into the plastome and homo-
plasmic state were assessed by Southern blot. Total
DNA, extracted from leaves from three different
spectinomycin-resistant lines previously characterized
by PCR, was employed for restriction enzyme diges-
tion with NcoI. This enzyme, which is absent in the
transgenic cassette, recognize sequence both upstream
and downstream of the integration site. After digestion
wild-type and transplastomic plastomes are expected
to generate a 6.4 kbp and 8.1 kbp DNA fragment,
respectively. A trnI/A probe was employed for
Southern blot analysis, confirming the transgenic state
for all three independent StrEGF lines (Fig. 1c).
A residual band of 6.4 kbp, corresponding to the
wild-type plastome could still be observed in all
transplastomic lines. Considering that the transplas-
tomic plants were subjected to three consecutive
rounds of regeneration under antibiotic selection,
followed by germination in spectinomycin-containing
media (Fig. 2b), it would be highly unlikely that these
plants exhibited a heteroplasmic state. The observed
additional hybridization signal could be explained by
additional copies of plastid DNA in the nuclear or
mitochondrial genome in the plant cells (Ruf et al.
2000). It has been proven that large copies of plastid
DNA integrated into the other genomes during evo-
lution (Ayliffe et al. 1998; Nakazono and Hirai 1993;
Stern and Lonsdale 1982).
Phenotypic comparison between transplastomic
StrEGF plants,a transplastomic EGF line and wild-
type counterparts revealed stunted growth in the three
StrEGF lines (Fig. 2a). Despite this observation, all
transplastomic lines exhibited normal plant architec-
ture. The fact that all seeds were able to germinate in
spectinomycin containing media (Fig. 2b) confirmed
the inheritance of the selection marker and absence of
untransformed plastomes suggesting plants
homoplasmy.
Analysis of transcript generation
Total leaf RNA extraction followed by northern blot
assay was employed to evaluate the presence of
expected RNAs containing the StrEFG sequence for
all transplastomic lines. An EGF probe was employed
to detect the three main transcription products:
monocistronic transcripts transcribed from the psbA
promoter (0.6 kbp 1), bicistronic transcripts generated
from the rrn promoter (Prrn) (1.6 kbp 2) and a
polycistronic transcript generated by read-through
from the endogenous rrn operon promoter (3.3 kbp
3) (Fig. 3a).
Total leaf RNA extracted from a stromal localized
EGF transplastomic line was employed as a molecular
weight reference. As expected, all the different types
of StrEGF containing transcripts showed retarded
electrophoretic mobility when compared to the EGF
sample, due to the additional Str sequence. In order to
further confirm the identity of the transcripts, the
hEGF probe was removed and the membrane
hybridized with an aadA probe. For this particular
probe, only polycistronic and bicistronic transcript
detection was expected. As observed, all the tran-
scripts exhibited the expected molecular weight sizes
(Fig. 3b). The third northern blot done on the same
membrane, was revealed with a probe corresponding
to the TrnI/A sequence. In this blot it is possible to
verify the equal loading of all samples including the
wild type, the specificity of the hybridization in the
previous assays and the complexity of the different
transcripts considering precursors, intermediates and
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matured molecules. This complexity is enhanced not
only by alternative sites of transcription initiation and
termination but also by RNA specific process as
maturation and splicing (Stern et al. 2010).
Analysis of recombinant StrEGF expression
The expression of StrEGF in transplastomic leaves
was assessed by western blot employing a monoclonal
antibody raised against EGF (Fig. 4). Total protein
extracts obtained from leaves of transplastomic
StrEGF lines (sE) exhibited specific bands that were
absent in both EGF (E) and wild-type (Wt) samples
included as controls. The molecular weight observed
for these specific bands (* 12 kDa) is compatible
with hEGF being in a dimer conformation. Additional
bands with higher molecular weight could probably
represent multimeric aggregated states of EGF that
resisted denaturing SDS-PAGE conditions (Fig. 4).
Protein extracted from E. coli previously transformed
with pBSW-utrStrEGF vector (sE) showed a band
of * 14 kDa consistent with an unprocessed StrEGF
monomer still containing the Str signal peptide
(* 8 kDa) fused to the EGF peptide (* 6 kDa).
This observation could be easily explained by the
lack of a bacteria-specific thylakoid-specific protease.
According to western blot analysis the vast majority
of recombinant StrEGF was found in insoluble
extracts (I) and could not be detected in soluble




a Nicotiana tabacum (L. cv.
Petit Havana) lines were
grown under greenhouse
conditions and phenotypes
were registered 16 weeks
post sowing (side and top
views). b 100 seeds of each
line were germinated in MS
medium containing
spectinomycin (0.5 g/l). The
pictures were taken 7 days
after sowing the seeds. E,
transplastomic line for






Transplastomic plants have a great potential for the
production of new molecules. However, the accumu-
lation level of recombinant proteins in plastids cannot
be predicted beforehand and every new protein is a
novel challenge (Bock 2014; Maliga and Bock 2011;
Scotti et al. 2012). This is especially relevant when
protein degradation by the housekeeping machinery is
triggered by misfolding of the polypeptide. An
example of this is the recombinant hEGF expressed
in the chloroplast stroma. Previous publications (Sch-
lapschy and Skerra 2011; Tong et al. 2001) and our
own experience (Wirth et al. 2006) suggest that the
acquisition of correct hEGF folding depends on proper
disulfide bond formation. In our previous attempts
using nuclear transgenic plants, the accumulation of
hEGF proved to be unsuccessfull in the reducing
cytosolic environment. However, it could be detected
in the apoplastic space after its transit through the
endoplasmic reticulum which provided a more oxida-
tive environment to catalyze disulfide bond formation.
Additionally, when hEGF was expressed in the
chloroplast stroma a slight accumulation could only
be detected in the dark when the environment became
more oxidizing and remained undetectable in the light.
Fig. 3 Characterization of transcripts containing the aadA and
hEGF sequence of transplastomic plants. a northern blots using
egf (left panel), aadA (central panel) or trnI/A (right panel) 32P-
labeled probes. b Physical map showing expected transcript
sizes related to the RNA operon of the plastoma. (i) Mono-
cistronic transcript (0.6 kb), (ii) bicistronic transcript (1.6 kb).
(iii) Polycistronic (3.3 kb), (iv–vi) large RNA precursors
without RNA processing (7.2 kb, 8.2 kb and 9.9 kb) tran-
scripted from the same three promoters with the inclusion of six
other elements of the RNA operon (trnI, trnA, rrn23, rrn4.5,
rrn5 and trnR). E, transplastomic line for unfused EGF; Wt,
wild-type; 1-3, transplastomic strEGF lines
123
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A plausible explanation for this observation is that
disulfide bond formation could be hindered in the
reducing environment of the plastid stroma. If this was
the case, abnormal folding could subsequently target
this protein for degradation by chloroplast proteolytic
systems.
In bacteria, hEGF does not accumulate in the
reducing cytosol and it must be secreted to the
periplasm or extracellular space by the addition of a
signal peptide (Abdull Razis et al. 2008). The oxidiz-
ing periplasm is more suitable for the generation of
disulfide bonds, counting with specialized chaperone
machinery consisting of the DbsA oxidase and the
DsbC isomerase. Overexpression of DsbA in the
periplasm has already proven beneficial for the
accumulation of unstable recombinant proteins with
few disulfide bonds (Gundinger and Spadiut 2017;
Kondo et al. 2000; Maskos et al. 2003).
Given the chloroplast evolutionary origin, the
stroma and thylakoid lumen are equivalent to the
bacterial cytosolic and periplasmic space, respec-
tively. Based on the above observations we hypoth-
esized that redirection of recombinant EGF to the
more oxidative environment of thylakoid lumen could
facilitate disulfide bond formation allowing for correct
folding of the protein. By means of this approach, we
tried to prevent protein degradation in order to
increase hEGF accumulation in transplastomic plants.
For this purpose, we used the amino-terminal signal
peptide from the plastid 23 kDa protein of the oxygen-
evolving complex (Str) (Marques et al. 2004). Phys-
iologically, this signal peptide is cleaved off the
protein after translocation into the thylakoid lumen.
By means of a western blot assay, we observed that
StrEGF was processed in the transplastomic plants but
not in bacteria, where the signal peptidase is absent.
The processing of Str, releasing the peptide of mature
hEGF, allows us to conclude that the translocation of
hEGF towards thylakoids lumenal space was
successful.
Moreover, we observed that directing hEGF to the
thylakoid lumen notably improves accumulation
levels when compared to the almost unde-
tectable levels observed for stromal hEGF.
These results confirm the potential of lumenal
localization to enhance the accumulation of certain
Fig. 4 Expression of hEGF in transplastomic plants. Expres-
sion analysis (right panel). Lanes were loaded with total protein
extracts obtained from 4 mg of fresh leaf tissue. E, transplas-
tomic line for unfused EGF; Wt, wild-type; sE1-3, transplas-
tomic lines for strEGF. E. coli extracts obtained from wild type
or transformed bacterial expressing StrEGF (sE) were used as
positive controls. Solubility analysis (left panel): Lanes were
loaded with total (T), soluble (S) and insoluble (I) protein




recombinant proteins. They also suggest that hEGF
aggregation occurred after import into the thylakoids,
where it was not as susceptible to degradation as in the
stroma. Because hEGF remains at the insoluble
fraction, quantification of the recombinant protein
accumulation by ELISA was not possible. Why hEGF
accumulates better in the thylakoid lumen compared to
the stroma has not been clarified yet. Our hypothesis is
that the most oxidizing environment of the lumen
favors a better folding of the protein in that compart-
ment. Further studies are required in order to test it.
Recently, a novel plant enzyme localized in the
thylakoid membrane was discovered. This protein,
called lumen thiol oxidoreductase (LTO1 or AtV-
KOR-DsbA), exhibits a lumenal domain analogous to
the one of bacterial periplasmic DsbA protein which is
also capable of catalyzing disulfide bond formation
(Du et al. 2015). This domain could be the one
responsible for rapidly oxidizing cysteines, favoring
incorrect disulfide bonds formation and leading to
aggregation of hEGF leaving it insoluble. It was
previously shown that accumulation of hEGF in the
bacterial periplasm can be improved by overexpres-
sion of DsbA, DsbC and two peptidyl-prolyl iso-
merases with chaperone activity (Schlapschy and
Skerra 2011). Moreover, DsbA secreted from Bre-
vibacillus choshinensis was able to promote disulfide
bonds formation in vitro, leading to active recombi-
nant hEGF (Tanaka et al. 2001). Another explanation
could be the fact that in the lumen of the thylakoids
protease diversity is less when compare to other
compartments.
Although in most transplastomic plants unintended
phenotypes were not observed, sometimes chlorosis,
growth retardation, and sterility were reported (Ah-
mad et al. 2012; Corigliano et al. 2019; Lossl et al.
2003; Rigano et al. 2009; Scotti et al. 2009; Lentz et al.
2012; Scotti and Cardi 2014).
Previously we showed that accumulation of hEGF
in the plastid stroma can occurwithout associated
penalties (Wirth et al. 2006). However, when the same
protein was redirected to the thylakoid lumen, we
observed a negative impact on plant growth. Con-
versely, when we showed that accumulation ofE7CP
in the thylakoid lumen, using the same Str signal
peptide (StrE7CP) transplastomic plants presented a
normal phenotype, suggesting that neither Str signal
nor the saturation of the translocation machinery are
responsible for the observed phenotype (Morgenfeld
et al. 2014). These problems must be addressed before
considering Str fusion approach as an effective way of
producing functional therapeutic hEGF. In many
cases, this can be attenuated by properly agronomic
management such as grafting (Oey et al. 2009) and/or
the use of fertilizers (Bally et al. 2009). Moreover,
molecular approaches could be explored as comple-
mentary strategies, including alternative translocation
signals and inducible promoters (Bock 2014).
We can conclude that, the strategy explored in this
work improved the expression of hEGF in transplas-
tomic plants despite minor alterations observed on
transplastomic plants phenotype. Unfortunately, the
protein remained insoluble, a limitation that needs to
be overcome in order to develop an effective platform
to produce recombinant hEGF.
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